Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Risk of invasive pneumococcal disease in children and adults with asthma: a systematic review.

Boikos C, Quach C.

Vaccine. 2013 Oct 1;31(42):4820-6. doi: 10.1016/j.vaccine.2013.07.079. Epub 2013 Aug 17. Review.

PMID:
23965221
2.

Dosing regimen of the 23-valent pneumococcal vaccination: a systematic review.

Caya CA, Boikos C, Desai S, Quach C.

Vaccine. 2015 Mar 10;33(11):1302-12. doi: 10.1016/j.vaccine.2015.01.060. Epub 2015 Feb 3. Review.

PMID:
25660650
4.
5.

Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23).

Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices.

MMWR Morb Mortal Wkly Rep. 2010 Sep 3;59(34):1102-6.

6.

Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use.

Pilishvili T, Zell ER, Farley MM, Schaffner W, Lynfield R, Nyquist AC, Vazquez M, Bennett NM, Reingold A, Thomas A, Jackson D, Schuchat A, Whitney CG.

Pediatrics. 2010 Jul;126(1):e9-17. doi: 10.1542/peds.2009-2150. Epub 2010 Jun 14.

PMID:
20547641
7.

Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.

Hanna-Wakim R, Chehab H, Mahfouz I, Nassar F, Baroud M, Shehab M, Pimentel G, Wasfy M, House B, Araj G, Matar G, Dbaibo G; Lebanese Inter-Hospital Pneumococcal Surveillance Program.

Vaccine. 2012 Dec 31;30 Suppl 6:G11-7. doi: 10.1016/j.vaccine.2012.07.020.

PMID:
23228352
8.

How many individuals with asthma need to be vaccinated to prevent one case of invasive pneumococcal disease?

Okapuu JM, Chétrit E, Lefebvre B, Quach C.

Can J Infect Dis Med Microbiol. 2014 May;25(3):147-50.

9.

Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older.

Vila-Corcoles A, Ochoa-Gondar O, Guzmán JA, Rodriguez-Blanco T, Salsench E, Fuentes CM; EPIVAC Study Group.

BMC Infect Dis. 2010 Mar 18;10:73. doi: 10.1186/1471-2334-10-73.

10.

Epidemiology of invasive pneumococcal infection in children aged five years and under in Saudi Arabia: a five-year retrospective surveillance study.

Memish ZA, El-Saed A, Al-Otaibi B, Shaalan MA, Alola SA, Thaqafi AO.

Int J Infect Dis. 2010 Aug;14(8):e708-12. doi: 10.1016/j.ijid.2010.02.2242.

11.
12.

Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age.

Lucero MG, Dulalia VE, Parreno RN, Lim-Quianzon DM, Nohynek H, Makela H, Williams G.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004977. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD004977.

PMID:
15495133
13.

Epidemiology of invasive pneumococcal infection among hospitalized children aged less than 5 years in Oman.

Al Awaidy ST, Al Obeidani I, Al Busaidy SS, Al Mahrouqi S.

Vaccine. 2012 Dec 31;30 Suppl 6:G7-G10. doi: 10.1016/j.vaccine.2012.07.016.

PMID:
23228359
14.

Invasive pneumococcal disease among White Mountain Apache adults, 1991-2005.

Bliss SJ, Larzalere-Hinton F, Lacapa R, Eagle KR, Frizzell F, Parkinson A, Reid R, Craig M, Santosham M, O'Brien KL.

Arch Intern Med. 2008 Apr 14;168(7):749-55. doi: 10.1001/archinte.168.7.749.

PMID:
18413558
15.
16.
17.

The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: A systematic review and meta-analysis.

Kraicer-Melamed H, O'Donnell S, Quach C.

Vaccine. 2016 Mar 18;34(13):1540-50. doi: 10.1016/j.vaccine.2016.02.024. Epub 2016 Feb 17.

PMID:
26899372
18.

Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2008 Feb 15;57(6):144-8.

19.

Invasive pneumococcal and meningococcal disease: association with influenza virus and respiratory syncytial virus activity?

Jansen AG, Sanders EA, VAN DER Ende A, VAN Loon AM, Hoes AW, Hak E.

Epidemiol Infect. 2008 Nov;136(11):1448-54. doi: 10.1017/S0950268807000271. Epub 2008 Jan 23.

20.

Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age.

Lucero MG, Dulalia VE, Nillos LT, Williams G, Parreño RA, Nohynek H, Riley ID, Makela H.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD004977. doi: 10.1002/14651858.CD004977.pub2. Review.

PMID:
19821336
Items per page

Supplemental Content

Write to the Help Desk